Fludarabine
Jump to navigation
Jump to search
In medicine, fludarabine is a medication that is a antineoplastic agent. It is approved by the U.S. Food and Drug Administration for the palliative treatment chronic lymphocytic leukemia (CLL). It is structurally related to the naturally occurring base adenosine-monophosphate used in both DNA and RNA, but it contains a fluorine atom and the geometry of the ribose ring at position 2' is reversed from that of normal DNA.
References
External links
The most up-to-date information about Fludarabine and other drugs can be found at the following sites.
- Fludarabine - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Fludarabine - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Fludarabine - Detailed information from DrugBank.